Media Summary: Terri Conneran was diagnosed with non-small cell lung Learn more about how we are progressing with our Platform which includes a detailed explanation of iNKT Cells and our ... Learn more about ALA-01, our off-the-shelf invariant Natural Killer T (iNKT) cell

Arovella Moving Toward With First In Human Clinical Trials For Blood Cancer Treatment - Detailed Analysis & Overview

Terri Conneran was diagnosed with non-small cell lung Learn more about how we are progressing with our Platform which includes a detailed explanation of iNKT Cells and our ... Learn more about ALA-01, our off-the-shelf invariant Natural Killer T (iNKT) cell In this educational video, Dr. Yana G. Najjar, Associate Professor of Medicine and Director of the Following the Company's recent capital raising, this webinar discusses next steps for

Photo Gallery

Arovella moving toward with first-in-human clinical trials for blood cancer treatment
The iNKT Cell Therapy Revolution
LUNG CANCER CLINICAL TRIALS: Breakthrough Treatments You NEED to KNOW! | The Patient Story
Arovella focused on taking ALA 101 into the Clinic!
Arovella Therapeutics Presents at Emergence 2023
Blood cancer awareness: early detection and clinical trials improve treatment options
Arovella set to launch Phase 1 trial for breakthrough cancer therapy - ASX SMIDcaps
Progressing Patient Focused iNKT Cell Therapy
Your Guide to Cancer Clinical Trials: Understanding the Basics
Arovella's Monsoon Twilight Briefing
How Cancer Clinical Trials May Lead to Treatment Breakthroughs
Clinical Trials: What are They, How are They Run, and How Does My Doctor Decide on the Right One?
Sponsored
Sponsored
View Detailed Profile
Arovella moving toward with first-in-human clinical trials for blood cancer treatment

Arovella moving toward with first-in-human clinical trials for blood cancer treatment

Arovella

The iNKT Cell Therapy Revolution

The iNKT Cell Therapy Revolution

In this video, we are going

Sponsored
LUNG CANCER CLINICAL TRIALS: Breakthrough Treatments You NEED to KNOW! | The Patient Story

LUNG CANCER CLINICAL TRIALS: Breakthrough Treatments You NEED to KNOW! | The Patient Story

Terri Conneran was diagnosed with non-small cell lung

Arovella focused on taking ALA 101 into the Clinic!

Arovella focused on taking ALA 101 into the Clinic!

Arovella

Arovella Therapeutics Presents at Emergence 2023

Arovella Therapeutics Presents at Emergence 2023

Learn more about how we are progressing with our #iNKT Platform which includes a detailed explanation of iNKT Cells and our ...

Sponsored
Blood cancer awareness: early detection and clinical trials improve treatment options

Blood cancer awareness: early detection and clinical trials improve treatment options

September is

Arovella set to launch Phase 1 trial for breakthrough cancer therapy - ASX SMIDcaps

Arovella set to launch Phase 1 trial for breakthrough cancer therapy - ASX SMIDcaps

Arovella

Progressing Patient Focused iNKT Cell Therapy

Progressing Patient Focused iNKT Cell Therapy

Arovella

Your Guide to Cancer Clinical Trials: Understanding the Basics

Your Guide to Cancer Clinical Trials: Understanding the Basics

Clinical trials

Arovella's Monsoon Twilight Briefing

Arovella's Monsoon Twilight Briefing

Learn more about ALA-01, our off-the-shelf invariant Natural Killer T (iNKT) cell

How Cancer Clinical Trials May Lead to Treatment Breakthroughs

How Cancer Clinical Trials May Lead to Treatment Breakthroughs

One way researchers find

Clinical Trials: What are They, How are They Run, and How Does My Doctor Decide on the Right One?

Clinical Trials: What are They, How are They Run, and How Does My Doctor Decide on the Right One?

In this educational video, Dr. Yana G. Najjar, Associate Professor of Medicine and Director of the

CLDN18.2 data explainer

CLDN18.2 data explainer

Arovella

Moving Forward with Clinical Trials: Blood Cancers

Moving Forward with Clinical Trials: Blood Cancers

Stanford

2025 - Webinar - LLS Overview of Services: Clinical Trial Support Center (Part 3 of 3) -Leah Szumita

2025 - Webinar - LLS Overview of Services: Clinical Trial Support Center (Part 3 of 3) -Leah Szumita

The

"Blenrep Approved: A Breakthrough in Blood Cancer Treatment"

"Blenrep Approved: A Breakthrough in Blood Cancer Treatment"

Welcome

Arovella Therapeutics (ASX:ALA): A novel cell therapy treatment for cancers and tumours

Arovella Therapeutics (ASX:ALA): A novel cell therapy treatment for cancers and tumours

Arovella

Arovella Therapeutics Quarterly Update Webinar | April 2025

Arovella Therapeutics Quarterly Update Webinar | April 2025

Following the Company's recent capital raising, this webinar discusses next steps for